Kellett Schaffner Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Kellett Schaffner Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $24,240 - $28,925	-500 Reduced 9.84%	4,579 $234,000
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $40,117 - $44,857	693 Added 15.8%	5,079 $294,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $0 - $384	5 Added 0.11%	4,386 $340,000
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $318,148 - $350,392	4,381 New	4,381 $337,000

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kellett Schaffner Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Kellett Schaffner Wealth Advisors LLC with notifications on news.